Additional therapy for adults with HF and EF <40% who are stabilised and euvolemic after a recent decompensation event requiring IV diuretics and received best medical care (a betablocker, an ACE-I or ARB or sacubitril/valsartan and a sodium-glucose cotransporter 2 inhibitor).